SK bioscience-GSK Covid-19 vaccine candidate enters Phase III trial
The trial will compare the vaccine candidate to the AstraZeneca-Oxford Covid-19 vaccine in nearly 4,000 participants.
South Korea
Latest in
South Korea
SK bioscience to conduct Phase III trial of Covid-19 vaccine
The company is the first to receive regulatory approval in South Korea to conduct a Phase III trial of a…
Humanigen’s partners get approval to trial lenzilumab in South Korea
Telcon and KPM will perform a Phase I trial of the antibody for Covid-19 treatment at the Seoul National University…
Celltrion’s regdanvimab shows activity against Delta SARS-CoV-2 variant
The drug candidate also demonstrated efficacy against Beta, Gamma and Lambda variants.
Celltrion’s Covid-19 drug regdanvimab meets Phase III endpoints
Regdanvimab met the primary efficacy goal of a significant decrease in the risk of hospitalisation or death.
SK bioscience secures CEPI funds for Phase III Covid-19 vaccine trial
SK bioscience to receive up to $173.4m from CEPI to support the Phase III trial of its Covid-19 vaccine candidate,…
Bridge Biotherapeutics starts clinical trial of BBT-176 for lung cancer
Bridge Biotherapeutics has commenced the Phase I/II clinical trial of BBT-176 in non-small cell lung cancer (NSCLC) patients with osimertinib-resistant…
Aptabio to initiate Phase II oral Covid-19 therapy trial
South Korean company Aptabio is all set to initiate a Phase II trial of its oral therapy, APX-115, for treating…